240 results on '"Cuervas‐Mons, V"'
Search Results
2. Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir
3. Long-Term Survivors After Pediatric Liver Transplatation Are at Increased Risk for Development of Cardiovascular Disease Events: Analysis of 30 Cases
4. CC Genotype at rs12979860 of IL28B Is Associated With Lower Risk of New-onset Diabetes After Transplantation in Adult Patients With Liver Transplantation for Hepatitis C Cirrhosis
5. TT Genotype of Transforming Growth Factor Beta1 +869C/T Is Associated With the Development of Chronic Kidney Disease After Liver Transplantation
6. Toll-like Receptor 3 L412F Polymorphism May Protect Against Acute Graft Rejection in Adult Patients Undergoing Liver Transplantation for Hepatitis C-Related Cirrhosis
7. Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient
8. Breakthrough Rhinocerebral Mucormycosis in a Liver Transplant Patient Receiving Caspofungin
9. Right Adrenal Metastases of Hepatocarcinoma After Liver Transplantation: Case Report and Literature Review
10. Donor Infection and Transmission to the Recipient of a Solid Allograft
11. Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation
12. Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
13. Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation
14. Poster Board #-Session: P217-II De Novo Cardiovascular Risk Factors in the First Four Years after Liver Transplantation: Risk Factors and Influence on Survival.: Abstract# 1197
15. Five-Year Follow-up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplantation
16. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
17. Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals
18. HTLV-1 infection in solid organ transplant donors and recipients in Spain
19. Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals
20. Sir Peter Freyer Memorial Lecture and Surgical Symposium 15th and 16th September, 1995
21. Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation
22. Usefulness of mycophenolate mofetil in patients with chronic renal insufficiency after liver transplantation
23. De novo malignancies in liver transplantation
24. Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
25. Influence of Infection by Aspergillus in Arterial Complications After Liver Transplantation: Evolution and Results in 670 Transplants
26. Evaluation of liver transplantation for primary cancer of the liver
27. C10/09 THE BAYESIAN DIAGNOSTIC INCREMENT CONTRIBUTED BY ULTRASOUND (US) IN DIAGNOSIS (Dx) OF JAUNDICE
28. Hepatitis C Virus Sensitivity to Combined Antiviral Therapy in Liver Transplant Versus Immunocompetent Patients
29. Incidence and outcome of De Novo malignancies after liver transplantation
30. Late orthotopic liver retransplant: indications and survival
31. Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases
32. Results of Liver Transplantation in Patients With Previous Portosystemic Shunts
33. Therapy of Intractable Pruritus With MARS
34. Effect of colistin on reduction of biliary flow induced by endotoxin ofE. coli
35. De novo malignancies and liver transplantation
36. Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality
37. Cardiovascular morbidity and obesity in adult liver transplant recipients
38. Effectiveness of low-dose intramuscular Anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report
39. Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas
40. Recurrence of primary biliary cirrhosis after liver transplantation
41. FRI-230 - The presence of two or more baseline NS5A resistance associated substitutions jeopardizes DAA treatment success in HCV patients
42. FRI-208 - Rapid liver fibrosis regression after sustained virological response in HCV patients treated with direct acting antivirals
43. SAT-286 - Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4
44. SAT-209 - Ledipasvir/Sofosbuvir for Recurrent Hepatitis C in Liver Transplant Recipients: A Real-Life Spanish Multicentre Experience
45. SAT-201 - Rapid Changes in Cholesterol in Chronic Hepatitis C Patients Treated with Antivirals and Potential Impacton Cardiovascular Risk
46. SAT-088 - Results of Radiofrequency Ablation in a Cohort of Cirrhotic Patients at Liver Transplantation
47. FRI-453 - Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Genotype 1, after Liver Transplantation: Efficacy and Safety
48. FRI-474 - Efficacy and Clinical Impact of Daclatasvir-Based Antiviral Therapy in Severe Recurrent Hepatitis C after Liver Transplantation. Results from a Multicenter Spanish Group
49. Lipids and Lipoprotein Changes After Heart and Liver Transplantation in a Patient with Homozygous Familial Hypercholesterolemia
50. P0040 : Long-term cardiovascular mortality after liver transplantation: Analysis of risk factors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.